Positive effects of thyroid replacement therapy on assisted reproductive technology outcomes in women with subclinical hypothyroidism with positive thyroid peroxidase autoantibodies.

Subclinical hypothyroidism in vitro fertilization thyroid replacement therapy

Journal

F&S reports
ISSN: 2666-3341
Titre abrégé: F S Rep
Pays: United States
ID NLM: 101766618

Informations de publication

Date de publication:
Mar 2022
Historique:
received: 28 05 2021
revised: 13 11 2021
accepted: 17 11 2021
entrez: 7 4 2022
pubmed: 8 4 2022
medline: 8 4 2022
Statut: epublish

Résumé

To study the beneficial effects of thyroid replacement therapy (TRT) on pregnancy outcomes in patients with subclinical hypothyroidism (SCl hypoT) with respect to thyroid peroxidase (TPO) autoantibodies. Retrospective study of 706 patients. Not applicable. The study evaluated 706 patients, who were divided into 3 cohorts: euthyroid patients, with pre-in vitro fertilization thyroid-stimulating hormone levels of <2.5 μIU/mL; patients with SCl hypoT, defined as thyroid-stimulating hormone levels of >2.5 μIU/mL and <4 μIU/mL, who were not treated; and patients with SCl hypoT who received TRT. The 3 cohorts were further subclassified into 2 groups, each based on TPO antibody levels. The cohorts were compared for the effects of TRT on pregnancy outcomes. Identification of effects of TRT on assisted reproductive technology outcomes. Patients with SCl hypoT had significantly fewer positive pregnancy outcomes than euthyroid patients. Importantly, low-dose TRT was found to be beneficial in improving IVF success and pregnancy outcomes in patients with SCl hypoT. The original cohort of patients, further classified into 2 subgroups on the basis of antithyroid (TPO) antibodies, showed that low-dose TRT was associated with improved pregnancy outcomes in women with SCl hypoT and TPO-positive antibodies. Our findings demonstrate that low-dose TRT may be beneficial in improving in vitro fertilization success and pregnancy outcomes in women with SCl hypoT and TPO-positive antibodies.

Identifiants

pubmed: 35386496
doi: 10.1016/j.xfre.2021.11.006
pii: S2666-3341(21)00125-2
pmc: PMC8978068
doi:

Types de publication

Journal Article

Langues

eng

Pagination

32-38

Informations de copyright

© 2021 The Authors.

Références

J Thyroid Res. 2013;2013:148157
pubmed: 23762775
Fertil Steril. 2000 Dec;74(6):1063-70
pubmed: 11119728
Thyroid. 2016 Apr;26(4):580-90
pubmed: 26837268
Fertil Steril. 2013 Mar 15;99(4):1044-8
pubmed: 23394777
Eur J Obstet Gynecol Reprod Biol. 2014 Feb;173:53-7
pubmed: 24332278
CMAJ. 2017 Jul 17;189(28):E941
pubmed: 28716849
Endocrinol Metab Clin North Am. 2014 Jun;43(2):xvii-xviii
pubmed: 24891181
J Endocrinol Invest. 2008 Jan;31(1):79-84
pubmed: 18296910
Adv Clin Chem. 2013;61:127-52
pubmed: 24015601
Circulation. 2017 Nov 28;136(22):2100-2116
pubmed: 29061566
Endocr J. 2020 Aug 28;67(8):859-868
pubmed: 32336697
Open Access Maced J Med Sci. 2017 Oct 26;5(7):1042-1046
pubmed: 29362642
Nat Rev Endocrinol. 2015 Feb;11(2):65
pubmed: 25445847
J Clin Med. 2021 May 13;10(10):
pubmed: 34068288
Fertil Steril. 2020 Mar;113(3):587-600.e1
pubmed: 32192591
Hum Reprod. 2017 Sep 1;32(9):1779-1785
pubmed: 28854714
Endocrinol Metab (Seoul). 2015 Sep;30(3):343-51
pubmed: 26248858
Gen Comp Endocrinol. 2015 Oct 1;222:69-80
pubmed: 26188717
J Thyroid Res. 2013;2013:542692
pubmed: 23738229
Nucl Med Mol Imaging. 2015 Jun;49(2):115-21
pubmed: 26085856
Thyroid. 2000 May;10(5):445-6
pubmed: 10884195
Clin Med Res. 2016 Jun;14(2):83-92
pubmed: 27231117
Surg Oncol. 2010 Dec;19(4):200-7
pubmed: 19500972
Thyroid. 2014 Dec;24(12):1670-751
pubmed: 25266247
Med Clin North Am. 2012 Mar;96(2):203-21
pubmed: 22443971
Clin Endocrinol (Oxf). 2007 Mar;66(3):309-21
pubmed: 17302862
Head Neck. 2015 Apr;37(4):498-504
pubmed: 24435826
Singapore Med J. 2016 Oct;57(10):539-545
pubmed: 27779276
Mayo Clin Proc. 2009;84(1):65-71
pubmed: 19121255
Thyroid. 2012 Jun;22(6):631-6
pubmed: 22540326
Obstet Gynecol. 2005 Oct;106(4):753-7
pubmed: 16199632
J Assoc Physicians India. 2017 Feb;65(2):84-85
pubmed: 28457041
Biomed Res Int. 2014;2014:517125
pubmed: 24877108
Eur J Intern Med. 2007 May;18(3):253-4
pubmed: 17449404
Eur Thyroid J. 2014 Jun;3(2):73-5
pubmed: 25114870
Drug Des Devel Ther. 2012;6:1-11
pubmed: 22291465
Arch Gynecol Obstet. 2019 Oct;300(4):805-819
pubmed: 31399840

Auteurs

Himanshu Arora (H)

Department of Urology, Miller School of Medicine, University of Miami, Miami, Florida.

Ineabelle Collazo (I)

IVFMD, South Florida Institute for Reproductive Medicine, Miami, Florida.

Katherine L Palmerola (KL)

IVFMD, South Florida Institute for Reproductive Medicine, Miami, Florida.

Madhumita Parmar (M)

Department of Urology, Miller School of Medicine, University of Miami, Miami, Florida.

Manish Narasimman (M)

Department of Urology, Miller School of Medicine, University of Miami, Miami, Florida.

Nicholas Hendon (N)

IVFMD, South Florida Institute for Reproductive Medicine, Miami, Florida.

Juergen Eisermann (J)

IVFMD, South Florida Institute for Reproductive Medicine, Miami, Florida.

Maria Bustillo (M)

IVFMD, South Florida Institute for Reproductive Medicine, Miami, Florida.

Classifications MeSH